Clinical Trial Application (CTA) submission marks the advancement of Tangram’s GalOmic RNAi platform into clinical development LONDON, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Tangram Therapeutics (‘Tangram’ ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results